Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-015146

Chief Financial Officer sold 3,426 shares at $232.05 ($795,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2023-05-09 Sale −3,426 $232.05 $795,000 103,516 D: show line 1 in the form
Open-market sales · 3,426 sh · avg $232.05 · $795,000
Loading xslF345X04/form4.xml…